These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 6111423

  • 1. The 1980 Bernard B. Brodie award lecture. Drug metabolism by cytochrome P-450: progress and perspectives.
    Coon MJ.
    Drug Metab Dispos; 1981; 9(1):1-4. PubMed ID: 6111423
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Studies on the molecular function of cytochrome P-450 during drug metabolism.
    Estabrook RW, Matsubara T, Mason JI, Werringloer J, Baron J.
    Drug Metab Dispos; 1973; 1(1):98-110. PubMed ID: 4149428
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Interaction of constitutive and phenobarbital-induced cytochrome P-450 isozymes during the sequential oxidation of benzphetamine. Explanation for the difference in benzphetamine-induced hydrogen peroxide production and 455-nm complex formation in microsomes from untreated and phenobarbital-treated rats.
    Jeffery EH, Mannering GJ.
    Mol Pharmacol; 1983 May; 23(3):748-57. PubMed ID: 6865917
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Drug metabolism in a reconstituted system by diabetes-dependent hepatic cytochrome P-450.
    Past MR, Cook DE.
    Res Commun Chem Pathol Pharmacol; 1982 Jul; 37(1):81-90. PubMed ID: 6812187
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Features of the metabolism of various drugs involving cytochrome P-450 isoenzymes].
    Filimonova AA, Ziganshin AU, Ziganshina LE.
    Eksp Klin Farmakol; 2007 Jul; 70(3):69-77. PubMed ID: 17650639
    [Abstract] [Full Text] [Related]

  • 11. Interactions of drug metabolites with hepatic cytochrome P-450. Some implications for drug metabolism.
    Bast A.
    Pharm Weekbl Sci; 1982 Aug 20; 4(4):113-4. PubMed ID: 7133961
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Reductive cleavage of hydroperoxides by cytochrome P-450.
    Vaz AD, Coon MJ.
    Methods Enzymol; 1990 Aug 20; 186():278-82. PubMed ID: 2233300
    [No Abstract] [Full Text] [Related]

  • 15. The characterization of an inhibitory complex formed with cytochrome P-450 and a metabolite of 1,1-disubstituted hydrazines.
    Hines RN, Prough RA.
    J Pharmacol Exp Ther; 1980 Jul 20; 214(1):80-6. PubMed ID: 7391974
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Influence of dietary thiamin on phenobarbital induction of rat hepatic enzymes responsible for metabolizing drugs and carcinogens.
    Wade AE, Evans JS, Holmes D, Baker MT.
    Drug Nutr Interact; 1983 Jul 20; 2(2):117-30. PubMed ID: 6432511
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The antibiotic tiamulin is a potent inducer and inhibitor of cytochrome P4503A via the formation of a stable metabolic intermediate complex. Studies in primary hepatocyte cultures and liver microsomes of the pig.
    Witkamp RF, Nijmeijer SM, Monshouwer M, Van Miert AS.
    Drug Metab Dispos; 1995 May 20; 23(5):542-7. PubMed ID: 7587928
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.